↓ Skip to main content

The breast cancer genome - a key for better oncology

Overview of attention for article published in BMC Cancer, November 2011
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (57th percentile)
  • Good Attention Score compared to outputs of the same age and source (66th percentile)

Mentioned by

twitter
4 tweeters

Citations

dimensions_citation
6 Dimensions

Readers on

mendeley
46 Mendeley
citeulike
1 CiteULike
Title
The breast cancer genome - a key for better oncology
Published in
BMC Cancer, November 2011
DOI 10.1186/1471-2407-11-501
Pubmed ID
Authors

Hans Kristian Moen Vollan, Carlos Caldas

Abstract

Molecular classification has added important knowledge to breast cancer biology, but has yet to be implemented as a clinical standard. Full sequencing of breast cancer genomes could potentially refine classification and give a more complete picture of the mutational profile of cancer and thus aid therapy decisions. Future treatment guidelines must be based on the knowledge derived from histopathological sub-classification of tumors, but with added information from genomic signatures when properly clinically validated. The objective of this article is to give some background on molecular classification, the potential of next generation sequencing, and to outline how this information could be implemented in the clinic.

Twitter Demographics

The data shown below were collected from the profiles of 4 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 46 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 2 4%
Portugal 1 2%
Brazil 1 2%
Unknown 42 91%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 12 26%
Researcher 9 20%
Student > Master 6 13%
Other 5 11%
Unspecified 4 9%
Other 10 22%
Readers by discipline Count As %
Agricultural and Biological Sciences 17 37%
Medicine and Dentistry 13 28%
Unspecified 4 9%
Biochemistry, Genetics and Molecular Biology 3 7%
Social Sciences 3 7%
Other 6 13%

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 February 2013.
All research outputs
#6,576,728
of 12,372,945 outputs
Outputs from BMC Cancer
#1,463
of 4,558 outputs
Outputs of similar age
#90,106
of 217,338 outputs
Outputs of similar age from BMC Cancer
#89
of 278 outputs
Altmetric has tracked 12,372,945 research outputs across all sources so far. This one is in the 46th percentile – i.e., 46% of other outputs scored the same or lower than it.
So far Altmetric has tracked 4,558 research outputs from this source. They receive a mean Attention Score of 3.9. This one has gotten more attention than average, scoring higher than 66% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 217,338 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 57% of its contemporaries.
We're also able to compare this research output to 278 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 66% of its contemporaries.